Key result
Female sex is linked to ~10% lower absolute all-cause mortality versus males in ACS.
Why the study?
Sex-specific differences in acute coronary syndrome management and mortality outcomes remain incompletely understood, particularly how age and treatment disparities influence female survival advantage.
Does female sex compared to male sex affect all-cause mortality in patients with acute coronary syndrome?
Observational (n=184,616)
Yes
Does female sex compared to male sex affect all-cause mortality in patients with acute coronary syndrome?
Despite presenting with more complex clinical profiles and receiving less intensive treatment, women with acute coronary syndrome demonstrate a significant survival advantage over men after adjusting for baseline differences and treatment gaps.
Answers are grounded in this paper and cite their sources.
Female survival advantage in ACS after matching should not change practice; leaves open confirmation in prospective studies.
BACKGROUND AND AIMS: This nationwide registry study examined sex-specific differences in acute coronary syndrome management and all-cause mortality in Hungary between 2014 and 2024. METHODS: Data from 184,616 patients in the Hungarian National Myocardial Infarction Register were analyzed. Median follow-up was 3.1 years (interquartile range: 0.8-6.2 years). Mortality was assessed using univariable and multivariable methods, Cox regression, Kaplan-Meier analysis, and propensity score matching for age, acute coronary syndrome subtype, revascularization status, and diabetes mellitus, yielding 141,342 matched individuals. RESULTS: Female patients were older and had higher rates of diabetes and hypertension, whereas males more often received timely percutaneous coronary intervention and guideline-recommended therapies. Unadjusted mortality was higher among females (1-year mortality: 25.7% vs. 19.8%). After matching, however, females showed a 10.3 percentage-point lower all-cause mortality than males (p < 0.001). This association varied by age and acute coronary syndrome subtype: it was strongest in younger and middle-aged patients and those with NSTEMI, attenuated among patients aged ≥75 years, and reversed among patients with STEMI. CONCLUSIONS: Although females present with more complex clinical profiles and receive less intensive treatment, the observed association between sex and mortality changed substantially and heterogeneously after adjustment for measured baseline differences, varying by age and acute coronary syndrome subtype. These findings highlight the importance of addressing sex-based disparities in acute coronary syndrome care and ensuring equitable access to diagnosis, guideline-recommended therapies, and revascularization.
No takes yet. Share an insight, caveat, or question.
Sári et al. (2026) conducted an observational in Acute coronary syndrome (n=184,616). Female sex vs. Male sex was evaluated on All-cause mortality (10.3 percentage-point lower, p=<0.001). After propensity score matching, female patients with acute coronary syndrome had a 10.3 percentage-point lower all-cause mortality compared to males.
Synapse has enriched 10 related papers. Consider them for comparative context: